The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD)

Nutrients

Volumn 4, Issue 12, 2012, Pages 1828-1850

  Chang, Melissa I ^a   Puder, Mark ^a   Gura, Kathleen M ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Fish oil; Intestinal failure related liver disease; Lipid emulsions; Parenteral nutrition; Pediatrics

Indexed keywords

ALPHA TOCOPHEROL; COCONUT OIL; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; LIPID EMULSION; OLIVE OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHYTOSTEROL; POLYUNSATURATED FATTY ACID; SOYBEAN OIL; TOCOPHEROL;

DIET SUPPLEMENTATION; DIET THERAPY; ESSENTIAL FATTY ACID DEFICIENCY; FAT INTAKE; FATTY ACID METABOLISM; HUMAN; INFLAMMATION; INTESTINAL FAILURE ASSOCIATED LIVER DISEASE; LIPID STORAGE; LIVER DISEASE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PARENTERAL NUTRITION; PATHOGENESIS; PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 84870705804     PISSN: 20726643     EISSN: None     Source Type: Journal    
DOI: 10.3390/nu4121828     Document Type: Review

References (139)

1. Dudrick, S.J.; Wilmore, D.W.; Vars, H.M.; Rhoads, J.E. Long-term total parenteral nutrition with growth, development, and positive nitrogen balance. Surgery 1968, 64, 134-142.
2. Squires, R.H.; Duggan, C.; Teitelbaum, D.H.; Wales, P.W.; Balint, J.; Venick, R.; Rhee, S.; Sudan, D.; Mercer, D.; Martinez, J.A., et al. Natural history of pediatric intestinal failure: Initial report from the pediatric intestinal failure consortium. J. Pediatr. 2012, 161, 723-728.
3. Quiros-Tejeira, R.E.; Ament, M.E.; Reyen, L.; Herzog, F.; Merjanian, M.; Olivares-Serrano, N.; Vargas, J.H. Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: A 25-year experience. J. Pediatr. 2004, 145, 157-163.
4. Willis, T.C.; Carter, B.A.; Rogers, S.P.; Hawthorne, K.M.; Hicks, P.D.; Abrams, S.A. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis. JPEN J. Parenter. EnteralNutr. 2010, 34, 32-37.
5. Chan, S.; McCowen, K.C.; Bistrian, B.R.; Thibault, A.; Keane-Ellison, M.; Forse, R.A.; Babineau, T.; Burke, P. Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition. Surgery 1999, 126, 28-34.
6. Diamanti, A.; Basso, M.S.; Castro, M.; Calce, A.; Pietrobattista, A.; Gambarara, M. Prevalence of life-threatening complications in pediatric patients affected by intestinal failure. Transplant. Proc. 2007, 39, 1632-1633.
7. Andorsky, D.J.; Lund, D.P.; Lillehei, C.W.; Jaksic, T.; Dicanzio, J.; Richardson, D.S.; Collier, S.B.; Lo, C.; Duggan, C. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J. Pediatr. 2001, 139, 27-33.
8. Beath, S.V.; Davies, P.; Papadopoulou, A.; Khan, A.R.; Buick, R.G.; Corkery, J.J.; Gornall, P.; Booth, I.W. Parenteral nutrition-related cholestasis in postsurgical neonates: Multivariate analysis of risk factors. J. Pediatr. Surg. 1996, 31, 604-606.
9. Christensen, R.D.; Henry, E.; Wiedmeier, S.E.; Burnett, J.; Lambert, D.K. Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease. J. Perinatol. 2007, 27, 284-290.
10. Burr, G.O.; Burr, M.M. A new deficiency disease produced by the rigid exclusion of fat from the diet. J. Biol. Chem. 1929, 82, 230-234.
11. Holman, R.T. The ratio of trienoic: Tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement. J. Nutr. 1960, 70, 405-410.
12. Connor, W.E. Pathogenesis and frequency of essential fatty acid deficiency during total parenteral nutrition. Ann. Intern. Med. 1975, 83, 895-896.
13. Tashiro, T.; Ogata, H.; Yokoyama, H.; Mashima, Y.; Iwasaki, I. The effect of fat emulsion of essential fatty acid deficiency during intravenous hyperalimentation in pediatric patients. J. Pediatr. Surg. 1975, 10, 203-213.
14. Friedman, A.; Moe, S. Review of the effects of omega-3 supplementation in dialysis patients. Clin. J. Am. Soc. Nephrol. 2006, 1, 182-192.
15. Smit, E.N.; Muskiet, F.A.; Boersma, E.R. The possible role of essential fatty acids in the pathophysiology of malnutrition: A review. Prostaglandins Leukot. Essent. Fatty Acids 2004, 71, 241-250.
16. Holman, R. Essential fatty acid deficiency. Prog. Chem. Fats Other Lipids 1971, 9, 275-348.
17. Mohrhauer, H.; Holman, R.T. The effect of dose level of essential fatty acids upon fatty acid composition of the rat liver. J. Lipid Res. 1963, 4, 151-159.
18. Clarke, S.D.; Jump, D.B. Dietary polyunsaturated fatty acid regulation of gene transcription. Annu. Rev. Nutr. 1994, 14, 83-98.
19. Browning, J.D.; Horton, J.D. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 2004, 114, 147-152.
20. Jump, D.B. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr. Opin. Lipidol. 2008, 19, 242-247.
21. Wang, Y.; Botolin, D.; Christian, B.; Busik, J.; Xu, J.; Jump, D.B. Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases. J. Lipid Res. 2005, 26, 706-715.
22. Xu, H.E.; Lambert, M.H.; Montana, V.G.; Parks, D.J.; Blanchard, S.G.; Brown, P.J.; Sternbach, D.D.; Lehmann, J.M.; Wisely, G.B.; Willson, T.M.; Kliewer, S.A.; Milburn, M.V. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol. Cell 1999, 3, 397-403.
23. Kliewer, S.A.; Mangelsdorf, D.J. Fibroblast growth factor 21: From pharmacology to physiology. Am. J. Clin. Nutr. 2010, 91, 254S-257S.
24. Inagaki, T.; Dutchak, P.; Zhao, G.; Ding, X.; Gautron, L.; Parameswara, V.; Li, Y.; Goetz, R.; Mohammadi, M.; Esser, V., et al. Endocrine regulation of the fasting response by PPARa-mediated induction of fibroblast growth factor 21. CellMetab. 2007, 5, 415-425.
25. Park, Y.; Harris, W. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J. Lipid Res. 2003, 44, 455-463.
26. Fisher, E.A.; Williams, K.J. Autophagy of an oxidized, aggregated protein beyond the ER: A pathway for remarkably late-stage quality control. Autophagy 2008, 4, 721-723.
27. Brodsky, J.L.; Fisher, E.A. The many intersecting pathways underlying apolipoprotein B secretion and degradation. Trends Endocrinol. Metab. 2008, 19, 254-259.
28. Ginsberg, H.N.; Fisher, E.A. The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism. J. Lipid Res. 2009, 50, S162-S166.
29. Jump, D.B.; Botolin, D.; Wang, Y.; Xu, J.; Demeure, O.; Christian, B. Docosahexaenoic acid (DHA) and hepatic gene transcription. Chem. Phys. Lipids 2008, 153, 3-13.
30. Das, U.N. Essential fatty acids: Biochemistry, physiology, and pathology. Biotechnol. J. 2006, 1, 420-439.
31. Dichtl, W.; Ares, M.P.; Jonson, A.N.; Jovinge, S.; Pachinger, O.; Giachelli, C.M.; Hamsten, A.; Eriksson, P.; Nilsson, J. Linoleic acid-stumulated vascular adhesion molecule-1 expression in endothelial cells depends on nuclear factor-kappa B activation. Metabolism 2002, 51, 327-333.
32. Park, H.J.; Lee, Y.W.; Hennig, B.; Toberek, M. Linoleic acid-induced VCAM-1 expression in human microvascular endothelial cells is mediated by the NF-kappa B-dependent pathway. Nutr. Cancer 2001, 41, 126-134.
33. Calder, P. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 2007, 77, 327-335.
34. Wall, R.; Ross, R.P.; Fitzgerald, G.F.; Stanton, C. Fatty acids from fish: The anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr. Rev. 2010, 68, 280-289.
35. Sijben, J.W.C.; Calder, P.C. Differential immunomodulation with long chain n-3 PUFA in health and chronic disease. Proc. Nutr. Soc. 2007, 66, 237-259.
36. Node, K.; Huo, Y.; Ruan, X.; Yang, B.; Spiecker, M.; Klaus, L.; Zeldin, D.C.; Liao, J.K. Anti-inflammatory Properties of Cytochrome P450 Epoxygenase-Derived Eicosanoids. Science 1999, 285, 1276-1279.
37. Spector, A.A.; Fang, X.; Snyder, G.D.; Weintraub, N.L. Epoxyeicosatrienoic Acids (EETs): Metabolism and Biochemical Function. Prog. Lipid Res. 2004, 43, 55-90.
38. Cleland, L.G.; James, M.J.; Proudman, S.M. The role of fish oils in the treatment of rheumatoid arthritis. Drugs 2003, 63, 845-853.
39. Bagga, D.; Wang, L.; Farias-Eisner, R.; Glaspy, J.A.; Reddy, S.T. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc. Natl. Acad. Sci. USA 2003, 100, 1751-1756.
40. Bellenger, J.; Bellenger, S.; Clement, L.; Mandard, S.; Diot, C.; Poisson, J.P.; Narce, M. A new hypotensive polyunsaturated fatty acid dietary combination regulates oleic acid accumulation by suppression of stearoyl CoA desaturase gene 1 gene expression in the SHR model of genetic hypertension. FASEB J. 2004, 18, 773-775.
41. Oh, D.Y.; Talukdar, S.; Bae, E.J.; Imamura, T.; Morinaga, H.; Fan, W.; Li, P.; Lu, W.J.; Watkins, S.M.; Olefsky, J.M. GPR120 is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-Inflammatory and Insulin Sensitizing Effects. Cell 2010, 142, 687-698.
42. Zhao, Y.; Joshi-Barve, S.; Barve, S.; Chen, L.H. Eicosapentaenoic acid prevents LPS-induced TNF-a expression by preventing NF-kB activation. J. Am. Coll. Nutr. 2004, 23, 71-78.
43. Calder, P.C. Mechanisms of Action of (n-3) Fatty Acids. J. Nutr. 2012, 142, 592-599.
44. Leaf, A.; Weber, P.C. Cardiovascular effects of n-3 fatty acids. N. Engl. J. Med. 1988, 318, 549-557.
45. Schmidt, E.B.; Dyerberg, J. Omega-3 fatty acids. Current status in cardiovascular medicine. Drugs 1994, 47, 405-424.
46. Grimminger, F.; Wahn, H.; Mayer, K.; Kiss, L.; Walmrath, D.; Seeger, W. Impact of arachidonic versus eicosapentaenoic acid on exotonin-induced lung vascular leakage: Relation to 4-series versus 5-series leukotriene generation. Am. J. Respir. Crit. Care Med. 1997, 155, 513-519.
47. Lee, T.H.; Hoover, R.L.; Williams, J.D.; Sperling, R.I.; Ravalese, J., III; Spur, B.W.; Robinson, D.R.; Corey, E.J.; Lewis, R.A.; Austen, K.F. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N. Engl. J. Med. 1985, 312, 1217-1224.
48. Levy, B.D.; Clish, C.B.; Schmidt, B.; Gronert, K.; Serhan, C.N. Lipid mediator class switching during acute inflammation: Signals in resolution. Nat. Immunol. 2001, 2, 612-619.
49. Serhan, C.N.; Hong, S.; Gronert, K.; Colgan, S.P.; Devchand, P.R.; Mirick, G.; Moussignac, R.L. Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 2002, 8, 1025-1037.
50. Bannenberg, G.L.; Chiang, N.; Ariel, A.; Arita, M.; Tjonahen, E.; Gotlinger, K.H.; Hong, S.; Serhan, C.N. Molecular circuits of resolution: Formation and actions of resolvins and protectins. J. Immunol. 2005, 174, 4345-4355.
51. Connor, K.M.; SanGiovanni, J.P.; Lofqvist, C.; Aderman, C.M.; Chen, J.; Higuchi, A.; Hong, S.; Pravda, E.A.; Majchrzak, S.; Carper, D., et al. Increased dietary intake of omega-3 polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med. 2007, 13, 868-873.
52. Seki, H.; Fukunaga, K.; Arita, M.; Nakanishi, H.; Taguchi, R.; Miyasho, T.; Takamiya, R.; Asano, K.; Ishizaka, A.; Takeda, J.; Levy, B.D. The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J. Immunol. 184, 836-843.
53. Duffield, J.S.; Hong, S.; Vaidya, V.S.; Lu, Y.; Fredman, G.; Serhan, C.N.; Bonventre, J.V. Resolvin D series and protectin D1 mitigate acute kidney injury. J. Immunol. 2006, 177, 5902-5911.
54. Recchiuti, A.; Krishnamoorthy, S.; Fredman, G.; Chiang, N.; Serhan, C.N. MicroRNAs in resolution of acute inflammation: Identification of novel resolvin D1-miRNA circuits. FASEB J. 25, 544-560.
55. Xu, Z.Z.; Zhang, L.; Liu, T.; Park, J.Y.; Berta, T.; Yang, R.; Serhan, C.N.; Ji, R.R. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat. Med. 2010, 592-597.
56. Gonzalez-Periz, A.; Horrillo, R.; Ferre, N.; Gronert, K.; Dong, B.; Moran-Salvador, E.; Titos, E.; Martinez-Clemente, M.; Lopez-Parra, M.; Arroyo, V.; Claria, J. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: A role for resolvins and protectins. FASEB J. 2009, 6, 1946-1957.
57. Vanek, V.W.; Seidner, D.L.; Allen, P.; Bistrian, B.; Collier, S.; Gura, K.; Miles, J.M.; Valentine, C.J.; Kochevar, M. Novel Nutrient Task Force, Intravenous Fat Emulsions Workgroup; American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. position paper: Clinical role for alternative intravenous fat emulsions. Nutr. Clin. Pract. 2012, 27, 150-192.
58. Wanten, G.J.; Calder, P.C. Immune modulation by parenteral lipid emulsions. Am. J. Clin. Nutr. 2007, 85, 1171-1184.
59. Seidner, D.L.; Mascioli, E.A.; Istfan, N.W.; Porter, K.A.; Selleck, K.; Blackburn, G.L.; Bistrian, B.R. Effects of long chain triglyceride emulsions on reticuloendothelial system function in humans. JPEN J. Parenter. Enteral Nutr. 1989, 13, 614-619.
60. Battistella, F.D.; Widergren, J.T.; Anderson, J.T.; Siepler, J.K.; Weber, J.C.; MacColl, K. A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition. J. Trauma 1997, 43, 52-60.
61. Cober, M.P.; Teitelbaum, D.H. Prevention of parenteral nutrition-associated liver disease: Lipid minimization. Curr. Opin. Organ. Transplant. 2010, 15, 330-333.
62. Meisel, J.A.; Le, H.D.; de Meijer, V.E.; Nose, V.; Gura, K.M.; Mulkern, R.V.; Akhavan Sharif, M.R.; Puder, M. Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model. J. Pediatr. Surg. 2011, 46, 666-673.
63. Driscoll, D.F. Lipid injectable emulsions: 2006. Nutr. Clin. Pract. 2006, 21, 381-386.
64. Freund, H.R. Abnormalities of liver function and hepatic damage associated with total parenteral nutrition. Nutrition 1991, 7, 1-6.
65. Greenberg, G.R.; Wolman, S.L.; Christofides, N.D.; Bloom, S.R.; Jeejeebhoy, K.N. Effect of total parenteral nutrition on gut hormone release in humans. Gastroenterology 1981, 80, 988-993.
66. Yeh, S.L.; Chen, W.J.; Huang, P.C. Effects of L-glutamine on induced hepatosteatosis in rats receiving total parenteral nutrition. J. Formos. Med. Assoc. 1995, 94, 593-599.
67. Kubota, A.; Yonekura, T.; Hoki, M.; Oyanagi, H.; Kawahara, H.; Yagi, M.; Imura, K.; Iiboshi, Y.; Wasa, K.; Kamata, S.; Okada, A. Total parenteral nutrition-associated intrahepatic cholestasis in infants: 25 years' experience. J. Pediatr. Surg. 2000, 35, 1049-1051.
68. Moss, R.L.; Das, J.B.; Ansari, G.; Raffensperger, J.G. Hepatobiliary dysfunction during total parenteral nutrition is caused by infusate, not the route of administration. J. Pediatr. Surg. 1993, 391-397.
69. Day, C.P.; James, O.F.W. Steatohepatitis: A tale of two "hits"? Gastroenterology 1998, 114, 842-845.
70. Kaminski, D.L.; Adams, A.; Jellinek, M. The effect of hyperalimentation on hepatic lipid content and lipogenic enzyme activity in rats and man. Surgery 1980, 88, 93-100.
71. Hultin, M.; Carneheim, C.; Rosenqvist, K.; Olivecrona, T. Intravenous lipid emulsions: Removal mechanisms as compared to chylomicrons. J. Lipid Res. 1995, 36, 2174-2184.
72. Li, S.J.; Nussbaum, M.S.; McFadden, D.W.; Dayal, R.; Fischer, J.E. Reversal of hepatic steatosis in rats by addition of glucagon to total parenteral nutrition (TPN). J. Surg. Res. 1989, 46, 557-566.
73. Rangel, S.J.; Calkins, C.M.; Cowles, R.A.; Barnhart, D.C.; Huang, E.Y.; Abdullah, F.; Arca, M.J.; Teitelbaum, D.H.; 2011 American Pediatric Surgical Association Outcomes and Clinical Trials Committee. Parenteral nutrition-associated cholestasis: An American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J. Pediatr. Surg. 2012, 225-240.
74. Qi, K.; Al-Haideri, M.; Seo, T.; Carpentier, Y.A.; Deckelbaum, R.J. Effects of particle size on blood clearance and tissue uptake of lipid emulsions with different triglyceride compositions. JPEN J. Parenter. EnteralNutr. 2003, 27, 58-64.
75. Feldstein, A.E.; Canbay, A.; Angulo, P.; Taniai, M.; Burgart, L.J.; Lindor, K.D.; Gores, G.J. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003, 125, 437-443.
76. Dandona, P.; Aljada, A.; Bandyopadhyay, A. Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol. 2004, 25, 4-7.
77. Ruan, H.; Lodish, H.F. Insulin resistance in adipose tissue: Direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev. 2003, 14, 447-455.
78. Angulo, P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 2002, 346, 1221-1231.
79. Li, H.; Miyahara, T.; Tezuka, Y.; Tran, Q.L.; Seto, H.; Kadota, S. Effect of berberine on bone mineral density in SAMP6 as a senile osteoporosis model. Biol. Pharm. Bull. 2003, 26, 110-111.
80. Feingold, K.R.; Soued, M.; Grunfeld, C. Tumor necrosis factor stimulates DNA synthesis in the liver of intact rats. Biochem. Biophys. Res. Commun. 1988, 153, 576-582.
81. Feldstein, A.E.; Canbay, A.; Guicciardi, M.E.; Higuchi, H.; Bronk, S.F.; Gores, G.J. Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J. Hepatol. 2003, 39, 978-983.
82. Mullick, F.G.; Moran, C.A.; Ishak, K.G. Total parenteral nutrition: A histopathologic analysis of the liver changes in 20 children. Mod. Pathol. 1994, 7, 190-194.
83. Kaufman, S.S.; Pehlivanova, M.; Fennelly, E.M.; Rekhtman, Y.M.; Gondolesi, G.E.; Little, C.A.; Matsumoto, C.S.; Fishbein, T.M. Predicting liver failure in parenteral nutrition-dependent short bowel syndrome of infancy. J. Pediatr. 2010, 156, 580-585.e1.
84. Nehra, D.; Fallon, E.M.; Puder, M. The prevention and treatment of intestinal failure-associated liver disease in neonates and children. Surg. Clin. North Am. 2011, 91, 543-563.
85. Goulet, O.; Joly, F.; Corriol, O.; Colomb-Jung, V. Some new insights in intestinal failure-associated liver disease. Curr. Opin. Organ. Transplant. 2009, 14, 256-261.
86. Keim, N.L.; Mares-Perlman, J.A. Development of hepatic steatosis and essential fatty acid deficiency in rats with hypercaloric, fat-free parenteral nutrition. J. Nutr. 1984, 114, 1807-1815.
87. Goheen, S.C.; Larkin, E.C.; Rao, G.A. Severe fatty liver in rats fed a fat-free ethanol diet, and its prevention by small amounts of dietary arachidonate. Lipids 1983, 18, 285-290.
88. Javid, P.; Greene, A.; Garza, J.; Gura, K.; Alwayn, I.P.; Voss, S.; Nose, V.; Satchi-Fainaro, R.; Zausche, B.; Mulkern, R.V.; Jaksic, T.; Bistrian, B.; Folkman, J.; Puder, M. The route of lipid administration affects parenteral nutrition-induced hepatic steatosis in a mouse model. J. Pediatr. Surg. 2005, 40, 1446-1453.
89. Xu, Z.; Harvey, K.A.; Pavlina, T.; Dutot, G.; Hise, M.; Zaloga, G.P.; Siddiqui, R.A. Steroidal compounds in commercial parenteral lipid emulsions. Nutrients 2012, 4, 904-921.
90. Ostlund, R.E., Jr. Phytosterols in human nutrition. Annu. Rev. Nutr. 2002, 22, 533-549.
91. Clayton, P.T.; Whitfield, P.; Iyer, K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 1998, 14, 158-164.
92. Salen, G.; Ahrens, E.H., Jr.; Grundy, S.M. Metabolism of beta-sitosterol in man. J. Clin. Invest. 1970, 49, 952-967.
93. Repa, J.J.; Berge, K.E.; Pomajzl, C.; Richardson, J.A.; Hobbs, H.; Mangelsdorf, D.J. Regulation of ATP binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J. Biol. Chem. 2002, 277, 18793-18800.
94. Ostlund, R.E., Jr.; McGill, J.B.; Zeng, C.M.; Covey, D.F.; Stearns, J.; Stenson, W.F.; Spilburg, C.A. Gastrointestinal absorption and plasma kinetics of soy Delta(5)-phytosterols and phytostanols in humans. Am. J. Physiol. Endocrinol. Metab. 2002, 282, E911-E916.
95. Van Aerde, J.E.; Duerksen, D.R.; Gramlich, L.; Meddings, J.B.; Chan, G.; Thomson, A.B.; Clandinin, M.T. Intravenous fish oil emulsion attenuates total parenteral nutrition-induced cholestasis in newborn piglets. Pediatr. Res. 1999, 45, 202-208.
96. Iyer, K.R.; Spitz, L.; Clayton, P. BAPS Prize Lecture: New insight into mechanisms of parenteral nutrition-associated cholestasis: Role of plant sterols. British Association of Paediatric Surgeons. J. Pediatr. Surg. 1998, 33, 1-6.
97. Clayton, P.T.; Bowron, A.; Mills, K.A.; Massoud, A.; Casteels, M.; Milla, P.J. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology 1993, 1806-1813.
98. Ling, W.H.; Jones, P.J. Dietary phytosterols: A review of metabolism, benefits and side effects. Life Sci. 1995, 57, 195-206.
99. Carter, B.A.; Taylor, O.A.; Prendergast, D.R.; Zimmerman, T.L.; Von Furstenberg, R.; Moore, D.D.; Karpen, S.J. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr. Res. 2007, 62, 301-306.
100. Shefer, S.; Salen, G.; Nguyen, L.; Batta, A.K.; Packin, V.; Tint, G.S.; Hauser, S. Competitive inhibition of bile acid synthesis by endogenous cholestanol and sitosterol in sitosterolemia with xanthomatosis Effect on cholesterol 7 alpha-hydroxylase. J. Clin. Invest. 1988, 82, 1833-1839.
101. Boberg, K.M.; Akerlund, J.E.; Björkhem, I. Effect of sitosterol on the rate-limiting enzymes in cholesterol synthesis and degradation. Lipids 1989, 24, 9-12.
102. Liu, Y.; Binz, J.; Numerick, M.J.; Dennis, S.; Luo, G.; Desai, B.; MacKenzie, K.I.; Mansfield, T.A.; Kliewer, S.A.; Goodwin, B.; Jones, S.A. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J. Clin. Invest. 2003, 112, 1678-1687.
103. Wanten, G.; Beunk, J.; Naber, A.; Swinkels, D. Tocopherol isoforms in parenteral lipid emulsions and neutrophil activation. Clin. Nutr. 2002, 21, 417-422.
104. Ames, B.N.; Shigenaga, K.; Hagen, T.M. Oxidants, antioxidants and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 1993, 90, 7915-7922.
105. Kohen, R.; Nyska, A. Oxidation of Biological Systems: Oxidative Stress Phenomena, Antioxidants, Redox Reactions, and Methods for Their Quantification. Toxicol. Pathol. 2002, 30, 620-650.
106. Hong, L.; Wang, X.; Wu, J.; Cai, W. Mitochondria-initiated apoptosis triggered by oxidative injury play a role in total parenteral nutrition-associated liver dysfunction in infant rabbit model. J. Pediatr. Surg. 2009, 44, 1712-1718.
107. Chung, M.Y.; Yeung, S.F.; Park, H.J.; Volek, J.S.; Bruno, R.S. Dietary a- and y-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis. J. Nutr. Biochem. 2010, 21, 1200-1206.
108. Soden, J.S.; Devereaux, M.W.; Haas, J.E.; Gumpricht, E.; Dahl, R.; Gralla, J.; Traber, M.G.; Sokol, R.J. Subcutaneous vitamin E ameliorates liver injury in an in vivo model of steatocholestasis. Hepatology 2007, 46, 485-495.
109. Becvarova, I.; Saker, K.E.; Swecker, W.S., Jr.; Troy, G.C. Peroxidative protection of parenteral admixture by D-alpha-tocopherol. Vet. Ther. 2005, 6, 280-290.
110. Sanyal, A.J.; Chalasani, N.; Kowdley, K.V.; McCullough, A.; Diehl, M.; Bass, M.; Neushwander-Tetri, B.A.; Lavine, J.E.; Tonascia, J.; Unalp, A., et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Eng. J. Med. 2010, 365, 1675-1685.
111. Lavine, J.E.; Schwimmer, J.B.; Van Natta, M.L.; Molleston, J.P.; Murray, K.F.; Rosenthal, P.; Abrams, S.H.; Scheimann, A.O.; Sanyal, A.J.; Chalasani, N., et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: The TONIC randomized controlled trial. JAMA 2011, 305, 1659-1668.
112. Strijbosch, R.A.M.; Lee, S.; Arsenault, D.A.; Andersson, C.; Gura, K.M.; Bistrian, B.R.; Puder, M. Fish oil prevents essential fatty acid deficiency and enhances growth: Clinical and biochemical implications. Metabolism 2008, 57, 698-707.
113. De Meijer, V.E.; Le, H.; Meisel, J.A.; Gura, K.M.; Puder, M. Parenteral fish oil as a monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J. Pediatr. Gastroenterol. Nutr. 2010, 50, 212-218.
114. Le, H.D.; de Meijer, V.E.; Robinson, E.; Zurakowski, D.; Potemkin, A.K.; Arsenault, D.A.; Fallon, E.M.; Malkan, A.; Bistrian, B.R.; Gura, K.M.; Puder, M. Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children. Am. J. Clin. Nutr. 2011, 94, 749-758.
115. Diamond, I.R.; Pencharz, P.B.; Feldman, B.M.; Ling, S.C.; Moore, A.M.; Wales, P.W. Novel lipid-based approaches to pediatric intestinal failure-associated liver disease. Arch. Pediatr. Adolesc. Med. 2012, 166, 473-478.
116. Nehra, D.; Le, H.D.; Fallon, E.M.; Carlson, S.J.; Woods, D.; White, Y.A.; Pan, A.H.; Guo, L.; Rodig, S.J.; Tilly, J.L.; Rueda, B.R.; Puder, M. Prolonging the female reproductive lifespan and improving egg quality with dietary omega-3 fatty acids. Aging Cell 2012, 11, 1046-1054.
117. Le, H.D.; Meisel, J.A.; de Meijer, V.E.; Fallon, E.M.; Gura, K.M.; Nose, V.; Bistrian, B.R.; Puder, M. Docosahexaenoic acid and arachidonic acid prevent essential fatty acid deficiency and hepatic steatosis. JPEN J. Parenter. Enteral. Nutr. 2012, 36, 431-441.
118. Gura, K.M.; Parsons, S.K.; Bechard, L.J.; Henderson, T.; Dorsey, M.; Phipatanakul, W.; Duggan, C.; Puder, M.; Lenders, C. Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin. Nutr. 2005, 24, 839-847.
119. Gura, K.M.; Duggan, C.P.; Collier, S.B.; Jennings, R.W.; Folkman, J.; Bistrian, B.R.; Puder, M. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: Implications for future management. Pediatrics 2006, 118, e197-e201.
120. Gura, K.M.; Lee, S.; Valim, C.; Zhou, J.; Kim, S.; Modi, B.P.; Arsenault, D.A.; Strijbosch, R.A.; Lopes, S.; Duggan, C.; Puder, M. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008, 121, 678-686.
121. Puder, M.; Valim, C.; Meisel, J.A.; Le, H.D.; de Meijer, V.E.; Robinson, E.M.; Zhou, J.; Duggan, C.; Gura, K.M. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann. Surg. 2009, 250, 395-402.
122. Ekema, G.; Falchetti, D.; Boroni, G.; Tanca, A.R.; Altana, C.; Righetti, L.; Ridella, M.; Gambarotti, M.; Berchich, L. Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids). J. Pediatr. Surg. 2008, 43, 1191-1195.
123. Cheung, H.M.; Lam, H.S.; Tam, Y.H.; Lee, K.H.; Ng, P.C. Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid. Clin. Nutr. 2009, 28, 209-212.
124. Strijbosch, R.A.; van den Hoonaard, T.L.; Olieman, J.F.; Escher, J.C.; Alwayn, I.P.; Meijers-Ijsselstijn, H. Fish oil in prolonged parenteral nutrition in children-omega-3-fatty acids have a beneficial effect on the liver. Ned. Tijdschr. Geneeskd. 2010, 154, A2003.
125. Calhoun, A.W.; Sullivan, J.E. Omegaven for the treatment of parenteral nutrition associated liver disease: A case study. J. Ky. Med. Assoc. 2009, 107, 55-57.
126. Pironi, L.; Colecchia, A.; Guidetti, M.; Belluzzi, A.; D'Errico, A. Fish oil-based emulsion for the treatment of parenteral nutrition associated liver disease in an adult patient. e-SPEN 2010, 5, e243-e246.
127. Jurewitsch, B.; Gardiner, G.; Naccarato, M.; Jeejeebhoy, K.N. Omega-3-enriched lipid emulsion for liver salvage in parenteral nutrition induced cholestasis in the adult patient. JPEN J. Parenter. Enteral Nutr. 2011, 35, 386-390.
128. Burns, D.L.; Gill, B.M. Reversal of parenteral nutrition-associated liver disease with fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition. JPEN J. Parenter. Enteral Nutr. 2012, in press.
129. Mallah, H.S.; Brown, M.R.; Rossi, T.M.; Block, R.C. Parenteral fish oil-associated burr cell anemia. J. Pediatr. 2010, 156, 324-326.
130. Grahn, E.P.; Dietz, A.A.; Stefani, S.S.; Donnelly, W.J. Burr cells, hemolytic anemia and cirrhosis. Am. J. Med. 1968, 45, 78-87.
131. Soden, J.S.; Lovell, M.A.; Brown, K.; Partrick, D.A.; Sokol, R.J. Failure of resolution of portal fibrosis during omega-3 fatty acid lipid emulsion therapy in two patients with irreversible failure. J. Pediatr. 2010, 156, 327-331.
132. Dimmitt, R.A.; Leadford, A.L.; Bartle, D.; Wilkinson, L.; Manimaran, V.; Harmon, M. Impact of Omega-3 Fatty Acids on Liver Function Test and Liver Histology in Children with Intestinal Failure Associated Intestinal Disease; Pediatric Academic Society: Boston, MA, USA, 2012; E-PAS2012:3830.366.
133. Diamond, I.R.; Sterescu, A.; Pencharz, P.B.; Kim, J.H.; Wales, P.W. Changing the paradigm: Omegaven for the treatment of liver failure in pediatric short bowel syndrome. J. Pediatr. Gastroenterol. Nutr. 2009, 48, 209-215.
134. Muhammed, R.; Bremner, R.; Protheroe, S.; Johnson, T.; Holden, C.; Murphy, S.M. Resolution of parenteral nutrition-associated jaundice on changing from a soybean oil emulsion to a complex mixed-lipid emulsion. J. Pediatr. Gastroenterol. Nutr. 2012, 54, 797-802.
135. Tomsits, E.; Pataki, M.; Tölgyesi, A.; Fekete, G.; Rischak, K.; Szollar, L. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: A randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J. Pediatr. Gastroenterol. Nutr. 2010, 51, 514-521.
136. Goulet, O.; Antebi, H.; Wolf, C.; Talbotec, C.; Alcindor, L.G.; Corriol, O.; Lamor, M.; Colomb-Jung, V. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: A single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN J. Parenter. Enteral Nutr. 2010, 34, 485-495.
137. Colomb, V.; Jobert-Giraud, A.; Lacaille, F.; Goulet, O.; Fournet, J.C.; Ricour, C. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J. Parenter. Enteral. Nutr. 2000, 24, 345-350.
138. Rubinos, L.H.; Ruth, J.S.; Hawthorne, K.; Abrams, S.A. Reducing Soy-BasedLipid Concentration May Not Prevent the Needfor Omega-3 Therapy in Parenteral Nutrition Associated Cholestasis; Pediatric Academic Society: Boston, MA, USA, 2012; E-PAS2012:3830.369.
139. Nehra, D.; Fallon, E.M.; Carlson, S.J.; Potemkin, A.K.; Hevelone, N.D.; Mitchell, P.D.; Gura, K.M.; Puder, M. Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates. JPEN J. Parenter. Enteral Nutr. 2012, in press.